vincamine has been researched along with Anemia, Sickle Cell in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Elbaum, D; Godoy, E; Nagel, RL; Roth, E | 2 |
2 other study(ies) available for vincamine and Anemia, Sickle Cell
| Article | Year |
|---|---|
Hydergine and vincamine derivative LD 4298 exhibit no anti-sickling properties in vitro.
Topics: Anemia, Sickle Cell; Dihydroergotoxine; Drug Evaluation; Humans; Vinca Alkaloids; Vincamine | 1979 |
Hydergine and vincamine derivative LD 4298 exhibit no anti-sickling properties in vitro.
Topics: Anemia, Sickle Cell; Dihydroergotoxine; Erythrocyte Membrane; Erythrocytes; Humans; Potassium; Vinca Alkaloids; Vincamine | 1978 |